Fasting levels of growth hormone are associated with carotid intima media thickness but are not affected by fluvastatin treatment

Table 1 Cross-sectional linear regression in the MDC-CC with IMT at baseline as dependent variable and hs-GH as independent. One crude model adjusted for sex and age and one model in addition adjusted for traditional cardiovascular risk factors^a

Dependent	Gender	Model^a	Beta^b	95%CI	P
IMT_max Bulb	ALL	Crude	0.060	0.020 to 0.099	0.003
	(n = 3397)	Adjusted	0.066	0.025 to 0.106	0.002
	MALE	Crude	0.075	0.025 to 0.125	0.003
	(n = 1440)	Adjusted	0.074	0.022 to 0.125	0.005
	FEMALE	Crude	0.029	−0.014 to 0.072	0.18
	(n = 1957)	Adjusted	0.038	−0.006 to 0.083	0.09
IMT_meanCCA	ALL	Crude	−0.012	−0.046 to 0.021	0.48
	(n = 4425)	Adjusted	0.017	−0.017 to 0.052	0.32
	MALE	Crude	0.011	−0.033 to 0.054	0.63
	(n = 1767)	Adjusted	0.024	−0.020 to 0.068	0.28
	FEMALE	Crude	−0.027	−0.063 to 0.009	0.15
	(n = 2658)	Adjusted	0.001	−0.036 to 0.038	0.97

^aCrude models adjusted for sex and age. Adjusted models adjusted for: sex, age, systolic blood pressure, antihypertensive medication, diabetes mellitus, current smoking, BMI, LDL-C and HDL-C
^bThe β coefficients are expressed as the increment of standardized values of the natural logarithm of IMT per 1 increment of standardized values of the natural logarithm of hs-GH

ISSN: 1471-2261